Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Klucher

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Virology|July 15, 2005
Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cellsPamela Osterlund, Ville Veckman, Jukka Sirén, et al.
Annals of the New York Academy of Sciences|January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis CDennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 28, 2012
Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeysKelly A Byrnes-Blake, Susan Pederson, Kevin M Klucher, et al.
EMBO Molecular Medicine|May 4, 2011
IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway diseaseOurania Koltsida, Michael Hausding, Athanasios Stavropoulos, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytesSean E Doyle, Heidi Schreckhise, Kien Khuu-Duong, et al.
Nature Immunology|December 7, 2002
IL-28, IL-29 and their class II cytokine receptor IL-28RPaul Sheppard, Wayne Kindsvogel, Wenfeng Xu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Virology|July 15, 2005
Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cellsPamela Osterlund, Ville Veckman, Jukka Sirén, et al.
Annals of the New York Academy of Sciences|January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis CDennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 28, 2012
Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeysKelly A Byrnes-Blake, Susan Pederson, Kevin M Klucher, et al.
EMBO Molecular Medicine|May 4, 2011
IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway diseaseOurania Koltsida, Michael Hausding, Athanasios Stavropoulos, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytesSean E Doyle, Heidi Schreckhise, Kien Khuu-Duong, et al.
Nature Immunology|December 7, 2002
IL-28, IL-29 and their class II cytokine receptor IL-28RPaul Sheppard, Wayne Kindsvogel, Wenfeng Xu, et al.
Pageof 1